Modelling interrupted time series to evaluate prevention and control of infection in healthcare

Epidemiology and Infection

Volumn 140, Issue 12, 2012, Pages 2131-2141

  Gebski, V ^a,b   Ellingson, K ^a   Edwards, J ^a   Jernigan, J ^a   Kleinbaum, D ^a,c  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c EMORY UNIVERSITY   (United States)

Author keywords

Methicillin resistant S. aureus (MRSA); modelling; public health

Indexed keywords

ACCURACY; ARTICLE; DISEASE TRANSMISSION; FOLLOW UP; HEALTH CARE; HOSPITAL; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LOGISTIC REGRESSION ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; POISSON DISTRIBUTION; PUBLIC HEALTH; REGRESSION ANALYSIS; STATISTICAL MODEL; TIME SERIES ANALYSIS;

EID: 84984936405     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812000179     Document Type: Article

References (25)

1. Klevens R, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007 298: 1763-1771. (Pubitemid 47598444)
2. Ellingson K, et al. Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention. Infection Control and Hospital Epidemiology 2011 32: 1-8.
3. Brown C Lilford R. The stepped wedge trial design a Systematic Review. BMC Medical Research Methodology 2006; 6 54
4. Smith P. Splines as a useful and convenient statistical tool. American Statistician 1979; 33: 57-62.
5. Kim H, et al. Comparability of segmented line regression models. Biometrics 2004; 60: 1005-1014. (Pubitemid 40019042)
6. Kim H, et al. Permutation tests for joinpoint regression with application to cancer rates. Statistics in Medicine 2000; 19: 335-351. (Pubitemid 30070608)
7. Cleveland W, Devlin S. Locally weighted regression : an approach to regression analysis by local fitting. American Statistician 1988; 83: 596-610.
8. Wagner AK, et al. Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 2002; 7: 299-309. (Pubitemid 34989269)
9. Matowe L, et al. Interrupted time series analysis in clinical research. Annals of Pharmacotherapy 2003; 37: 1110-1116. (Pubitemid 36875246)
10. Shardell M, et al. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clinical Infectious Diseases 2007; 45: 901-907. (Pubitemid 47580386)
11. Gillings D, Makuc D, Sigel E. Analysis of interrupted time series mortality trends : an example to evaluate regionalized perinatal care. American Journal of Public Health 1981; 71: 38-46. (Pubitemid 11207805)
12. Madden J, et al. Effects of a law against early postpartum discharge on newborn follow-up, adverse events and HMO expenditures. New England Journal of Medicine 2002; 347: 2031-2038. (Pubitemid 35461660)
13. Ross-Degnan D, et al. Examining product risk in context. Market withdrawal of zomepirac as a case study. Journal of the American Medical Association 1993; 270: 1937-1942. (Pubitemid 23312609)
14. Soumerai SB, et al. Payment restrictions for prescription drugs under Medicaid: effects on therapy, cost, and equity. New England Journal of Medicine 1987; 317: 550-556. (Pubitemid 17123270)
15. Mol P, et al. Improving compliance with hospital antibiotic guidelines : a time-series intervention analysis. Journal of Antimicrobial Chemotherapy 2005; 55: 550-557. (Pubitemid 40542599)
16. Haung S, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin- resistant Staphylococcus aureus bacteremia. Clinical Infectious Diseases 2006; 43: 971-978.
17. Bosso J, Mauldin P. Using interrupted time series to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2006; 50: 2106-2112. (Pubitemid 43807532)
18. Biglan A, Ary D, Wagenaar A. The value of interrupted time-series experiments for community intervention research. Prevention Science 2000; 1: 31-49.
19. Ferná ndez-Pe'rez C, Tejada J, Carrasco M. Multivariate time series analysis in nosocomial infection surveillance : a case study. International Journal of Epidemiology 1998; 27: 282-288. (Pubitemid 28203797)
20. Feng PJ, et al. Clinical incidence of methicillinresistant Staphylococcus aureus (MRSA) colonization or infection as a proxy measure for MRSA transmission in acute care hospitals. Infection Control and Hospital Epidemiology 2011; 32: 20-25.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7: 177-188. (Pubitemid 17189972)
22. Egger M, Davey Smith G, Altman D. Systematic Reviews in Health Care. Meta-analysis in Context. London: BMJ Books, 2001.
23. Bhargava A, Franzini L, Narendranathan W. Serial correlation and the fixed effects models. Review of Economic Studies 1982; 49: 533-549.
24. Hardin J, Hilbe J. Generalized Estimating Equations. London: Chapman and Hall/CRC London, 2003.
25. Marschner I, Gillett A. Relative risk regression : reliable and flexible methods for log-binomial models. Biostatistics 2012; 13; 179-192.